Lyndra

Long Acting Oral Drug Delivery Platform - Nortiva Bio

Watertown, United States · Founded 2015 · $286.5M raised

Headquarters
Watertown
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$286.5M
Last Round
$101.0M Series EDec 2023
Rounds
4

About

Lyndra Therapeutics is a clinical-stage biopharmaceutical company dedicated to reinventing medicine through long-acting oral therapies. Its proprietary LYNX platform is designed to deliver medicine for a week or longer in a single oral capsule, improving medication adherence for patients with chronic and infectious diseases. Founded in 2015 out of technology developed at MIT by Robert Langer, the company built a pipeline of therapies across multiple therapeutic areas.

Summary

Lyndra is a Biotech company based in Watertown, United States, founded in 2015. It has raised $286.5M in total across 4 rounds, most recently a $101.0M Series E round in Dec 2023. Investors include AIG, Polaris Partners and Gilead Sciences.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries EDec 2023
$101.0M

Sign up to see all 4 rounds

Series A through Series E — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lyndra on Indexed.vc
<a href="https://indexed.vc/companies/lyndra"><img src="https://indexed.vc/api/badge/company/lyndra" alt="Lyndra on Indexed.vc" width="260" height="76" /></a>